The AIDS virus, commonly known as the Human Immunodeficiency Virus (HIV), is a retrovirus that attacks the immune system, compromising its ability to defend the body against infections and diseases. It primarily spreads through unprotected sexual intercourse, sharing contaminated needles, and from an infected mother to her child during childbirth or breastfeeding. The progression of HIV infection occurs in stages, starting with the acute infection phase, followed by clinical latency, and ultimately leading to Acquired Immunodeficiency Syndrome (AIDS) if left untreated. Early symptoms may mimic flu-like conditions, but HIV can remain asymptomatic for years. Timely detection through testing is crucial for effective management and prevention of further transmission. Antiretroviral therapy (ART) serves as the primary treatment for HIV, slowing down the virus's progression and enabling individuals with HIV to lead relatively normal lives. Despite advancements in treatment, the global impact of the AIDS virus remains significant, necessitating ongoing efforts in education, prevention, and treatment accessibility. Challenges persist in addressing socio-economic disparities, stigma, and discrimination associated with HIV/AIDS, making collaborative global initiatives crucial for effective prevention and control.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation